Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 2, 2025Journal of Medical Case ReportsOpen Access

Synchronous triple-negative breast cancer, rectal adenocarcinoma, and chemotherapy-induced hepatitis B virus reactivation: a case report and review of the literature

View Full Paper
Ask AI
Bookmark
Share

Authors

AAAhmad Al‐BitarITIsraa TellawiHKHazem Kamil

Discussion

Loading...

Member takes

Overview

Case report details chemotherapy-related HBV reactivation in a patient with synchronous cancers, highlighting the importance of monitoring liver function.

Key Points

  • A 55-year-old woman had synchronous triple-negative breast cancer and rectal adenocarcinoma, with BRCA1/BRCA2 mutation.
  • Chemotherapy was complicated by hepatitis B virus reactivation, leading to significant liver inflammation and treatment changes.
  • Surgical interventions successfully removed both cancers, and the patient remains disease-free at a 3-year follow-up.
  • The case emphasizes the need for routine HBV screening and a multidisciplinary approach in cancer management.

Cite This Study

Al‐Bitar et al. (2025) studied this question.

synapsesocial.com/papers/689a0c7be6551bb0af8d054dhttps://doi.org/10.1186/s13256-025-05423-8
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Hepatitis B and/or C virus reactivation in patients receiving chemotherapy: An observational study2024
  2. 2Combined neoadjuvant chemotherapy and immunotherapy in a hepatitis B virus-positive patient with locally advanced rectal adenocarcinoma: a case report and literature review2025
  3. 3Prevalence and Reactivation of Hepatitis B and C in Patients Undergoing Chemotherapy for Solid Tumors2026
  4. 4Synchronous cholangiocarcinoma and cervical squamous cell carcinoma managed <i>via</i> a multidisciplinary approach: A case report2025
  5. 5Case report: surgery combined with a SOX adjuvant chemotherapy regimen for patients with gastric adenocarcinoma and hepatocellular carcinoma2025